Prosecution Insights
Last updated: July 17, 2026
Application No. 18/718,345

PESTICIDALLY ACTIVE PYRIDAZINONE COMPOUNDS

Non-Final OA
Filed
Jun 10, 2024
Priority
Dec 10, 2021 — IN 202111057521 +1 more
Examiner
ENGLISH, CONNOR KENNEDY
Art Unit
Tech Center
Assignee
Syngenta AG
OA Round
1 (Non-Final)
55%
Grant Probability
Moderate
1-2
OA Rounds
1y 3m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 55% of resolved cases
55%
Career Allowance Rate
22 granted / 40 resolved
-5.0% vs TC avg
Strong +54% interview lift
Without
With
+54.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
37 currently pending
Career history
77
Total Applications
across all art units

Statute-Specific Performance

§101
2.3%
-37.7% vs TC avg
§103
53.4%
+13.4% vs TC avg
§102
4.5%
-35.5% vs TC avg
§112
18.0%
-22.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 40 resolved cases

Prosecution Timeline

Jun 10, 2024
Application Filed
Jun 05, 2026
Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12637445
KIF18A INHIBITORS
4y 3m to grant Granted May 26, 2026
Patent 12600707
CANNABINOID DERIVATIVES, PRECURSORS AND USES
4y 1m to grant Granted Apr 14, 2026
Patent 12590098
PYRIMIDO PYRIMIDINONE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
3y 0m to grant Granted Mar 31, 2026
Patent 12582638
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, CONTAINING MTOR-SIGNALING INHIBITOR AS ACTIVE INGREDIENT
3y 7m to grant Granted Mar 24, 2026
Patent 12569563
SELECTIVE HDAC6 DEGRADERS AND METHODS OF USE THEREOF
3y 10m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
55%
Grant Probability
99%
With Interview (+54.5%)
3y 5m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 40 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month